Prohibition Partners Launches Interactive Platform with Real-Time Data on the European Cannabis Market
Prohibition Partners' interactive platform offers real-time data on the European cannabis market, ushering in a new era for investors, regulators, and industry companies
Published on 08/04/2025

Insights Hub | Image: disclosure
Prohibition Partners, one of the leading global cannabis market intelligence consultancies, has just launched its most ambitious project yet: the Insights Hub, an interactive digital platform that promises to revolutionize access to data and analysis about the sector. This innovation marks the transition from static reports to a dynamic, real-time environment, keeping pace with the speed of political and commercial transformations in the European cannabis market.
Available for free, the Insights Hub debuts with the 10th edition of the European Cannabis Report, a reference publication for investors, regulators, and industry operators worldwide. From now on, this content will be continuously accessible and interactive, allowing for data customization and visualizations according to each user's interest.
Real-Time Data for Over 30 European Countries
Highlights of the new platform include live monitoring of regulations, import and export data, licensing, and investment opportunities in over 30 European countries. The environment also features interactive graphics that facilitate the analysis of trends, public policies, medical access, and advancements in adult use.
Strategic Vision for a Constantly Evolving Sector
“Since 2017, we have been tracking the evolution of the cannabis markets in Europe. We knew it was time to offer something that kept up with the fast pace and complexity of the sector,” said Stephen Murphy, CEO of Prohibition Partners.
Free Tool for Investors, Companies, and Policymakers
The initiative meets a growing demand for reliable, real-time data, especially in a context of maturing European markets and legislative advancements in countries like Germany and Malta. The aim is to provide a tool that supports quick and informed decisions across the value chain — from patients and doctors to investors and policymakers.
Download for free now: